Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Identity and Access Management and Biometric Solutions Provider BIO-key Hosts Q3 Investor Call Friday, November 15th at 10am ET
-
KBW Earns Multiple No. 1 Spots in Influential Rankings
-
CervoMed to Participate in Upcoming Investor Conferences
-
Bel Fuse Announces Upcoming Investor Conference Schedule for November 2024
-
Palisade Bio Announces First Subject Dosed in Phase 1 Clinical Study of PALI-2108 for the Treatment of Moderate-to-Severe Ulcerative Colitis (UC)
-
Intelligent Bio Solutions Reports Fiscal 2025 First Quarter Financial Results and Operational Highlights
-
ConnectM to Participate in the 13th Annual Roth Technology Conference
-
KYN Capital Group Enhances KOINFOLD With Faster Transaction Speeds
-
PodcastOne (NASDAQ: PODC) Reports Q2 Fiscal 2025 Financial Results; Revenue Increases 16% YoY to $12.2 Million
-
KBW Earns Multiple No. 1 Spots in Influential Rankings
-
Ikena Oncology Reports Third Quarter 2024 Financial Results
-
Paltalk to Host Third Quarter 2024 Earnings Results Conference Call on Tuesday, November 12, 2024 at 4:30 p.m. ET
-
Workhorse Secures Multiple Orders for W56 Electric Step Vans in Parcel Delivery Market as Fleet Demand Increases
-
Volaris Reports October 2024 Traffic Results: Strong Demand Across Our Markets, Load Factor of 87%
-
Horizon Aircraft Simplifies Capital Structure with Mutual Termination of Forward Purchase Agreement with Meteora Capital
-
iCoreConnect Announces Expansion of Endorsement With The Arizona Dental Association (AzDA)
-
Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC
-
HYCU® Unveils Enhanced Data Protection for Box, Enabling Enterprise-Grade Backup and Recovery for More Than 115,000+ Organizations Worldwide
-
Saratoga Investment Corp. Announces Quarterly Dividend of $0.74 Per Share for the Fiscal Third Quarter Ending November 30, 2024
-
3D Systems Empowers Innovation, Transforms Industries with New Products at Formnext 2024
-
HeartCore to Present at Sidoti Micro-Cap Virtual Conference on November 14, 2024 at 11:30 a.m. ET
-
Femasys to Exhibit at the Annual AAGL 2024 Global Conference
-
Nexxen to Participate in the RBC Global Technology, Internet, Media and Telecommunications Conference
-
La Rosa Holdings to Unveil Proprietary Technology Advancements at Growth Summit 2024
-
2024 Guangxi Culture and Tourism Development Conference to Commence Soon
-
AdSure Invites Advertisers to Access Top-Quality Finance and Insurance Leads – 10% Conversion Guarantee for Top Funnel Live Leads
-
Trinity Biotech Regains Compliance with Nasdaq Listing Requirements
-
Enlight Announces a Power Purchase Agreement for the Snowflake A Project in Arizona
-
The Metals Company Announces Third Quarter 2024 Corporate Update Conference Call for Thursday, November 14, 2024
-
GlobalTech Corporation and Techtics AI Align to Drive Innovation in Emerging Technologies
-
2025 Travel Outlook: Squaremouth Predicts Traveler’s Destination and Spend Trends
-
Nortech Systems Reports Third Quarter Results
-
Third Harmonic Bio Announces Third Quarter 2024 Financial Results
-
AskBio Receives FDA Rare Pediatric Disease and Orphan-Drug Designations for AB-1003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9
-
Cavli Wireless is all set to introduce the LTE Cat 4 CQS315 Smart Module at Electronica Munich 2024
-
Ladybug Continues to Accelerate Growth Targeting Strategic Acquisitions
-
IMUNON Reports Third Quarter 2024 Financial Results and Provides Business Updates
-
Infineon and Stellantis Team Up to Advance Innovation in Power Conversion and Distribution for Next Generation of Vehicle Architectures
-
MEI: Increased government intervention during the Quiet Revolution was not responsible for rising living standards in Quebec
-
Representatives from Over 87 Countries to Participate in the International Symposium 'Creating the Future'
-
Representatives from Over 87 Countries to Participate in the International Symposium 'Creating the Future'
-
ROME Therapeutics to Present Data Supporting LINE-1 Reverse Transcriptase Inhibitors as a Novel Treatment for Autoimmune Diseases at ACR Convergence 2024
-
Mesa Labs Announces Second Quarter Results
-
Intra-Cellular Therapies Announces Presentations at the 2024 Psych Congress and NEI Congress
-
VYNE Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Vaxart to Host Third Quarter 2024 Business Update and Financial Results Conference Call on November 13
-
Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2024 Financial Results
-
Zscaler to Host First Quarter Fiscal Year 2025 Earnings Conference Call
-
Regina Hosts First Refugee Hiring Event
-
CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference
